Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer mortality, with new treatment options urgently needed. Neuropilins-1/-2 (NRP1, NRP2) are receptors for semaphorins and angiogenic growth factors, while the GAIP interacting protein C-terminus 1 (GIPC1, aka Synectin) interacts with...

Descripción completa

Detalles Bibliográficos
Autores principales: Borchardt, Hannes, Schulz, Alexander, Datta, Kaustubh, Muders, Michael H., Aigner, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820541/
https://www.ncbi.nlm.nih.gov/pubmed/31664117
http://dx.doi.org/10.1038/s41598-019-51881-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820541/
https://www.ncbi.nlm.nih.gov/pubmed/31664117
http://dx.doi.org/10.1038/s41598-019-51881-8

Ejemplares similares